MARKSANS vs FORTIS: Stock Comparison
Head-to-head financial and trading comparison between Marksans Pharma Limited (MARKSANS) and Fortis Healthcare Limited (FORTIS) in the Cross-Sector Peers sector.
MARKSANS
NSE: MARKSANSFORTIS
NSE: FORTISKey Metrics Comparison Table
| Metric | MARKSANS | FORTIS | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹309.10 | ₹786.25 | — |
| 1-Year Price Return | +74.73% | -11.75% | MARKSANS (86.48% higher) |
| 52-Week High | ₹347.60 | ₹990.35 | — |
| 52-Week Low | ₹176.77 | ₹763.00 | — |
| 30-Day Annualized Volatility | 42.37% | 30.52% | FORTIS (Steadier) |
| 30-Day Average Daily Volume | 2,394,723 | 1,709,157 | MARKSANS (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between MARKSANS and FORTIS, which stock gave better returns over the last year?
MARKSANS has outperformed FORTIS over the past 12 months with a gain of 74.73% compared to -11.75%.
Which stock is less volatile: MARKSANS or FORTIS?
FORTIS demonstrated lower price volatility (30.52% annualized) compared to MARKSANS (42.37%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of MARKSANS vs FORTIS?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are MARKSANS and FORTIS direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.